Gene · 55503
Papers1,976
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,976
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The impact of inducible-whole body or intestine-specific Cyp24a1 gene knockout on vitamin D metabolism in mice. | J Steroid Biochem Mol Biol | 2025 | 40096918 | PubTator, text mining | PubMed |
| Prebiotics as modulators of colonic calcium and magnesium uptake. | Acta Physiol (Oxf) | 2025 | 39803707 | PubTator, text mining | PubMed |
| The Influence of Phosphoinositide Lipids in the Molecular Biology of Membrane Proteins: Recent Insights from Simulations. | J Mol Biol | 2025 | 39793883 | PubTator, text mining | PubMed |
| Structure-function analyses of human TRPV6 ancestral and derived haplotypes. | Structure | 2025 | 39500315 | PubTator, text mining | PubMed |
| TRPV6 gene mutation associated with giant pancreatic pseudocyst with mediastinal extension in a pediatric patient: Lessons learned. | J Clin Ultrasound | 2025 | 39266467 | PubTator, text mining | PubMed |
| Curcumin ameliorates pyroptosis in diabetic seminal vesicles by upregulating TRPV6. | Andrology | 2025 | 38966878 | PubTator, text mining | PubMed |
| Overexpression of TRPV6 Inhibits Coronary Atherosclerosis-Related Inflammatory Response and Cell Apoptosis via the PKA/UCP2 Pathway. | Cardiovasc Ther | 2024 | 39742020 | PubTator, text mining | PubMed |
| The potential of TRP channels as new prognostic and therapeutic targets against prostate cancer progression. | Biochim Biophys Acta Rev Cancer | 2024 | 39586480 | PubTator, text mining | PubMed |
| Integrating deep learning architectures for enhanced biomedical relation extraction: a pipeline approach. | Database (Oxford) | 2024 | 39197056 | PubTator, text mining | PubMed |
| Fibroblast growth factor-21 potentiates the stimulatory effects of 1,25-dihydroxyvitamin D3 on transepithelial calcium transport and TRPV6 Ca2+ channel expression. | Biochem Biophys Res Commun | 2024 | 39053106 | PubTator, text mining | PubMed |
| Safety and Pharmacokinetics of a Combined Antioxidant Therapy against Myocardial Reperfusion Injury: A Phase 1 Randomized Clinical Trial in Healthy Humans. | Clin Pharmacol Drug Dev | 2024 | 38973337 | PubTator, text mining | PubMed |
| Selective 1,4-syn-Addition to Cyclic 1,3-Dienes via Hybrid Palladium Catalysis. | ACS Cent Sci | 2024 | 38947211 | PubTator, text mining | PubMed |
| Trpv6 channel targeting using monoclonal antibody induces prostate cancer cell apoptosis and tumor regression. | Cell Death Dis | 2024 | 38879621 | PubTator, text mining | PubMed |
| Air-Stable Cobalt(III) and Chromium(III) Complexes as Single-Component Catalysts for the Activation of Carbon Dioxide and Epoxides. | Inorg Chem | 2024 | 38670933 | PubTator, text mining | PubMed |
| Diagnostic yield of repeat genetic testing in idiopathic chronic pancreatitis. | Clin Res Hepatol Gastroenterol | 2024 | 38657903 | PubTator, text mining | PubMed |
| Advances in TRPV6 inhibitors for tumors by targeted therapies: Macromolecular proteins, synthetic small molecule compounds, and natural compounds. | Eur J Med Chem | 2024 | 38588625 | PubTator, text mining | PubMed |
| Naringenin Alleviates Radiation-Induced Intestinal Injury by Inhibiting TRPV6 in Mice. | Mol Nutr Food Res | 2024 | 38581304 | PubTator, text mining | PubMed |
| Characterization and Mechanism of a Novel Rice Protein Peptide (AHVGMSGEEPE) Calcium Chelate in Enhancing Calcium Absorption in Caco-2 Cells. | J Agric Food Chem | 2024 | 38563891 | PubTator, text mining | PubMed |
| The TRPV6 Calcium Channel and Its Relationship with Cancer. | Biology (Basel) | 2024 | 38534438 | PubTator, text mining | PubMed |
| Dilation of ion selectivity filters in cation channels. | Trends Biochem Sci | 2024 | 38514273 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55503/papers?page=5